I am pleased to invite you on behalf of the president of the International Myeloma Society, Nikhil Munshi, and of the local organizers Hermann Einsele, Hartmut Goldschmidt and Roman Hajek to attend the forthcoming 18th Multiple Myeloma Workshop in Vienna, Austria, September 8-11, 2021.
The meeting provides an extensive overview of the recent developments in basic research and clinical management of multiple myeloma and related diseases. In addition, novel research data will be presented in various oral and poster session and attendees will have the opportunity to obtain hands on information in ‘meet the professor’ sessions. The great debates on Saturday morning will be both very informative and highly enjoyable. In this session, experts are invited to present completely contrary positions on a specific topic. The presentations will be followed by mutual discussion where the speakers need to defend their arguments.
Congress attendees are invited to attend a welcome reception at the ‘Messe Wien Exhibition & Congress Center’ on Wednesday, late afternoon and the gala reception on Friday evening in the ‘Hofburg Palace’ in Vienna.
The congress will be organized as hybrid meeting but we very much hope that you will attend the workshop in person. For those participating online, sessions can be viewed life and on demand. Details about our commitment to COVID safety can be obtained here.
We are very confident that you will enjoy the meeting and the many cultural attractions of Vienna and very much hope to be able to welcome you.
Heinz Ludwig Roman Hajek Hermann Einsele Hartmut Goldschmidt
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.